Nutex Health Reports Strong Revenue Growth Amid Filing Delay

Clinigence Holdings Inc ( (NUTX) ) has released its Q2 earnings. Here is a breakdown of the information Clinigence Holdings Inc presented to its investors.

Nutex Health Inc., headquartered in Houston, Texas, is a healthcare management and operations company that specializes in micro-hospitals and provider networks across the United States. The company operates through two main divisions: a Hospital Division, which manages 24 facilities in 11 states, and a Population Health Management Division, which supports affiliated hospitals and physician groups.

In its latest earnings report, Nutex Health announced a delay in filing its second-quarter financial statements due to non-cash accounting adjustments related to stock-based compensation obligations. Despite this delay, the company provided preliminary financial results for the quarter and announced a $25 million stock repurchase program.

Key financial highlights for the quarter include a significant increase in total revenue, which rose to $244.0 million, marking a 220.7% increase from the same period in the previous year. The gross profit also saw a substantial rise, reaching $124.9 million, or 51.2% of total revenue. Additionally, the company reported an increase in total visits at its hospital division, with a 10.6% rise compared to the previous year.

For the six months ending June 30, 2025, Nutex Health reported total revenue of $455.8 million, a 217.5% increase from the same period in 2024. The gross profit for this period was $243.3 million, representing 53.4% of total revenue. The company also noted a 15.5% increase in total hospital visits.

Looking ahead, Nutex Health remains focused on addressing the accounting adjustments and plans to file its financial statements within the SEC-prescribed grace period. The company is optimistic about its growth trajectory, supported by its strategic initiatives, including the stock repurchase program aimed at enhancing shareholder value.